Cargando…
Response to “Modifications to the PREEMPT Protocol for OnabotulinumtoxinA Injections for Chronic Migraine in Clinical Practice”
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756747/ https://www.ncbi.nlm.nih.gov/pubmed/33107587 http://dx.doi.org/10.1111/head.13996 |
| _version_ | 1783626608961126400 |
|---|---|
| author | Blumenfeld, Andrew M. Silberstein, Stephen D. |
| author_facet | Blumenfeld, Andrew M. Silberstein, Stephen D. |
| author_sort | Blumenfeld, Andrew M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7756747 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77567472020-12-28 Response to “Modifications to the PREEMPT Protocol for OnabotulinumtoxinA Injections for Chronic Migraine in Clinical Practice” Blumenfeld, Andrew M. Silberstein, Stephen D. Headache Letters to the Editor John Wiley and Sons Inc. 2020-10-27 2020 /pmc/articles/PMC7756747/ /pubmed/33107587 http://dx.doi.org/10.1111/head.13996 Text en © 2020 The Authors. Headache: The Journal of Head and Face Pain published by Wiley Periodicals LLC on behalf of American Headache Society This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Letters to the Editor Blumenfeld, Andrew M. Silberstein, Stephen D. Response to “Modifications to the PREEMPT Protocol for OnabotulinumtoxinA Injections for Chronic Migraine in Clinical Practice” |
| title | Response to “Modifications to the PREEMPT Protocol for OnabotulinumtoxinA Injections for Chronic Migraine in Clinical Practice” |
| title_full | Response to “Modifications to the PREEMPT Protocol for OnabotulinumtoxinA Injections for Chronic Migraine in Clinical Practice” |
| title_fullStr | Response to “Modifications to the PREEMPT Protocol for OnabotulinumtoxinA Injections for Chronic Migraine in Clinical Practice” |
| title_full_unstemmed | Response to “Modifications to the PREEMPT Protocol for OnabotulinumtoxinA Injections for Chronic Migraine in Clinical Practice” |
| title_short | Response to “Modifications to the PREEMPT Protocol for OnabotulinumtoxinA Injections for Chronic Migraine in Clinical Practice” |
| title_sort | response to “modifications to the preempt protocol for onabotulinumtoxina injections for chronic migraine in clinical practice” |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756747/ https://www.ncbi.nlm.nih.gov/pubmed/33107587 http://dx.doi.org/10.1111/head.13996 |
| work_keys_str_mv | AT blumenfeldandrewm responsetomodificationstothepreemptprotocolforonabotulinumtoxinainjectionsforchronicmigraineinclinicalpractice AT silbersteinstephend responsetomodificationstothepreemptprotocolforonabotulinumtoxinainjectionsforchronicmigraineinclinicalpractice |